CBD OF DENVER, INC. (CBDD) Switzerland is Working on a Pilot Program to Permit Temporary Production and Sale of Marijuana.

PR Newswire

DENVER, Dec. 2, 2020 /PRNewswire/ — CBD of Denver, Inc. (OTC: CBDD), a full-line CBD and Hemp oil company (“CBDD”) selling Black Pearl CBD hemp products and a producer and distributor of CBD products in Switzerland today discusses the Swiss pilot program to permit temporary production and distribution of marijuana.

In June 2020 the lower house of Switzerland’s Federal Assembly approved a bill for a five-year pilot research program for the temporary production and distribution of cannabis to adults for recreational purposes. Marijuana Business Daily reported that it could lead to the normalization of cannabis in Switzerland. The pilot program is intended to provide scientific arguments for a national debate on the opportunity to legally regulate cannabis for adult consumers, according to an expert quoted in the Marijuana Business Daily article. The upper house, the Conseil des Etats approved the bill in September. The bill includes a provision that the cannabis is to be grown by Swiss farmers

“If the pilot program is successful, CBD of Denver, Inc, Rockflowr Exchange, Rockflowr Production and Rockflowr Retail could dramatically benefit by using their expertise in CBD and hemp industry to move into the very lucrative marijuana business” explained Marcel Gamma.

CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for all our shareholders

CBDD offers a superior CBD product that is full spectrum without depending on THC to activate the benefits of cannabidiol. Black Pearl CBD has 0% THC, but is not an Isolate where the THC is stripped from the product rendering it ineffective. We use a proprietary technique adding terpenes as the activation ingredient, resulting in a product that is the finest in the industry. Products are available and look for a new updated website soon at www.blackpearlcbd.com.

Information contained herein includes forward-looking statements. These statements relate to future events or future financial performance, involving known and unknown risks and you should not place undue reliance on these statements. Any forward-looking statement reflects our current views with respect to future events. We assume no obligation publicly about update or revise these forward-looking statements for any reason.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cbd-of-denver-inc-cbdd-switzerland-is-working-on-a-pilot-program-to-permit-temporary-production-and-sale-of-marijuana-301183559.html

SOURCE CBD of Denver, Inc.

iQIYI’s Live Action Adaptation of ‘Hikaru no Go’ a Big Hit with Chinese and International Audiences

‘Hikaru no Go’ Trends on Twitter, Achieves 8.4 Rating on China’s Douban

PR Newswire

BEIJING, Dec. 2, 2020 /PRNewswire/ — iQIYI Inc. (NASDAQ: IQ) (“iQIYI” or the “Company”), an innovative market-leading online entertainment service in China, is pleased to announce that its recently released original teen drama Hikaru no Go (the “Show”) has been well received both in China and internationally.

Hikaru no Go, which was adapted from the Japanese manga of the same name, has garnered widespread acclaim and sparked rounds of online discussion following each episode’s release.

Many overseas fans took to Twitter to praise the Show, with a significant of fans noting that Hikaru no Go exceeds their expectations in quality and that it captures the youthful and passionate spirit of the original manga. So far, the drama has received an 8.4 rating on movie review platform Douban, making it the highest-rated domestic drama series in the teen category this year.

The highly-rated hit drama, which has gained considerable attention and prompted heated discussions among audiences, has once again demonstrated the high quality of iQIYI’s content production. The success of Hikaru no Go in particular shows the progress that iQIYI has made in the teen genre and the Company’s ambitions of building global influence with its premium original content.

While Hikaru no Go has retained the manga’s original plot, some tweaks have been made to incorporate more Chinese culture into the story. As a result, the show has strongly resonated with domestic audiences, propelling its iQIYI content popularity index to above 7,448. According to data from market research firm Enlightenment, factors including the Show’s airtime, audience stickiness, and market share of the online drama market has grown consistently since its release, making it the most popular of the recently-released teen dramas.

As for its depiction of the game of Go, Hikaru no Go was highly praised by domestic mainstream media as well as Chang Hao, vice chairman of the Chinese Weiqi Association and well-known national Go player. In particular, People’s Daily (Overseas Edition) praised the drama for its youthful interpretation of Go culture, saying that iQIYI will encourage more young people to appreciate the charm of Go culture by introducing and promoting the game through a teen drama series.

Hikaru no Go was also a big hit on social media platforms, where it received overwhelmingly positive reviews from fans. The passion for Go, sincere friendships and stellar performances of the actors sparked heated discussions on social media platforms such as Douban and Weibo, and the hashtags ‘#Hikaru no Go‘ and ‘#Japanese netizens’ comments on Hikaru no Go‘ were trending. The main topic was viewed 770 million times and ‘fabulous drama Hikaru no Go‘ became top keywords in discussions among subscribers.

The passionate tale of Go competition has also enjoyed an enthusiastic reception from overseas subscribers. So far, seven episodes have been uploaded to iQIYI’s international YouTube channel, with an average of over 120,000 views per episode and the drama has been listed in the top five for all categories on iQIYI’s international platform in North America. The classic plot point of the “divine move”, which refers to the main character’s goal of playing the perfect game of Go, has attracted fans of the original manga and triggered ‘Go mania’ worldwide.

This year, a number of iQIYI’s premium original shows have received enormous attention both at home and abroad. Among them, iQIYI’s original drama series The Thunder became the first network premiere TV series to win the Magnolia Award and the “Outstanding TV Series” award at the 30th Golden Eagle Awards. This year’s hit Mist Theater dramas successfully entered the international arena with its highly innovative, well-crafted thriller mini-dramas, receiving attention from prominent overseas media outlets such as The Guardian and The Economist. Meanwhile, the drama The Bad Kids won two awards at the 2020 Busan International Film Festival’s 2nd Asian Contents Awards (ACA), making it the first Chinese drama to win the Best Creative Award at the ACA.

About iQIYI, Inc.

iQIYI, Inc. is an innovative market-leading online entertainment service in China. Its corporate DNA combines creative talent with technology, fostering an environment for continuous innovation and the production of blockbuster content. iQIYI’s platform features highly popular original content, as well as a comprehensive library of other professionally-produced content, partner-generated content and user generated content. The Company distinguishes itself in the online entertainment industry by its leading technology platform powered by advanced AI, big data analytics and other core proprietary technologies. iQIYI attracts a massive user base with tremendous user engagement, and has developed a diversified monetization model including membership services, online advertising services, content distribution, live broadcasting, online games, IP licensing, online literature and e-commerce.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/iqiyis-live-action-adaptation-of-hikaru-no-go-a-big-hit-with-chinese-and-international-audiences-301183681.html

SOURCE iQIYI, Inc.

Oramed Initiates Phase 2 NASH Trial of Oral Insulin

PR Newswire

NEW YORK, Dec. 2, 2020 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today it has screened the first patients in a global trial of its oral insulin capsule ORMD-0801 for the treatment of Nonalcoholic steatohepatitis (NASH).  The patients were screened at a U.S. site participating in Oramed’s trial, being conducted at U.S., EU and Israeli clinical sites.

Oramed Pharmaceuticals Logo

The trial will be comprised of eight clinical sites: three in the EU, three in the U.S. and two in Israel.  The trial will measure efficacy endpoints via MRI-PDFF for 12-weeks dosing.  For more information on the trial see: https://clinicaltrials.gov/ct2/show/NCT04616014?term=oramed&draw=2&rank=4.   

“Based on the strong results from our previous study, where ORMD-0801 showed a 30% relative reduction in liver fat, we are excited to be starting this important international NASH trial and we look forward to sharing the data as it becomes available,” stated Oramed CEO Nadav Kidron.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in New York and Israel, Oramed has developed a novel Protein Oral Delivery (POD™) technology. Oramed is seeking to transform the treatment of diabetes through its proprietary lead candidate, ORMD-0801, which has the potential to be the first commercial oral insulin capsule for the treatment of diabetes. The Company has completed multiple Phase II clinical trials under an Investigational New Drug application with the U.S. Food and Drug Administration. In addition, Oramed is developing an oral GLP-1 (Glucagon-like peptide-1) analog capsule, ORMD-0901.

For more information, please visit www.oramed.com.

Forward-looking statements:  This press release contains forward-looking statements. For example, we are using forward-looking statements when we discuss the future sites, data and patient enrollment for the NASH study, the potential efficacy and benefits of ORMD-801, the validation of preliminary findings in future trials, the potential of ORMD-0801 to be the first commercial oral insulin capsule for the treatment of diabetes or revolutionizing the treatment of diabetes with our products. In addition, historic results of scientific research and clinical trials do not guarantee that the conclusions of future research or trials will suggest identical or even similar conclusions. These forward-looking statements are based on the current expectations of the management of Oramed only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval or patent protection for our product candidates; competition from other pharmaceutical or biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; delays or obstacles in launching our clinical trials; changes in legislation; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further and lack of acceptance of our methods by the scientific community; inability to retain or attract key employees whose knowledge is essential to the development of our products; unforeseen scientific difficulties that may develop with our process; greater cost of final product than anticipated; loss of market share and pressure on pricing resulting from competition; laboratory results that do not translate to equally good results in real settings; our patents may not be sufficient; and finally that products may harm recipients, all of which could cause the actual results or performance of Oramed to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Oramed undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risks and uncertainties affecting Oramed, reference is made to Oramed’s reports filed from time to time with the Securities and Exchange Commission.

Company Contact
Estee Yaari  
+1-844-9-ORAMED
[email protected]

 

 

Cision View original content:http://www.prnewswire.com/news-releases/oramed-initiates-phase-2-nash-trial-of-oral-insulin-301183628.html

SOURCE Oramed Pharmaceuticals Inc.

Suzano Included in 2021 Corporate Sustainability Index

Suzano Included in 2021 Corporate Sustainability Index

The company is now on the list of companies evaluated by the B3

SÃO PAULO–(BUSINESS WIRE)–Suzano, a global reference in bioproducts derived from the cultivation of eucalyptus trees, was selected as a component of the Corporate Sustainability Index (ISE) of the Brazilian B3 Exchange for 2021. The ISE is an index that tracks the performance of listed corporations based on the aspects of corporate sustainability, social justice, environmental balance and corporate governance.

The company was included in the portfolio announced this week, which is composed of 46 stocks of 39 companies and is valid from January 4 to December 30, 2021. With its inclusion in the ISE, Suzano reaffirms its commitment to the long-term goals it announced in last February that include, among other measures, removing 40 million tons of additional carbon from the air by 2030, producing 10 million tons of biobased products to replace plastic and petroleum products and acting to remove 200,000 people from below the poverty line.

“Being included in this list reinforces that we are on the right path in our ESG practices. We will continue to work so that our activities continue to be recognized by independent evaluators and consequently associated with our ongoing evolution to build a sustainable economy,” said Marcelo Bacci, CFO and IRO of Suzano.

About Suzano

Suzano, the company resulting from the merger of Suzano Pulp & Paper and Fibria, is committed to being a global reference in the sustainable use of renewable resources. The world’s leading producer of eucalyptus pulp and one of Latin America’s largest paper producers, Suzano exports to more than 80 countries and, through its products, contributes to the lives of over two billion people. With its ten plants and the joint operation Veracel, it has installed capacity of 10.9 million tons of market pulp and 1.4 million tons of paper per year. Suzano has more than 35,000 direct and indirect employees, and has been investing for more than 90 years in innovative solutions based on planted eucalyptus, which enable it to replace fossil-based raw materials with those from renewable sources. Suzano adopts the highest standards of corporate governance on the exchanges where its stock is traded, namely the B3 in Brazil and the NYSE in the United States.

Planin – Suzano’s Media Relations

Angélica Consiglio, Beatriz Imenes and team – www.planin.com

Contact: Eduarda Lopes

[email protected] - Tel.: +55 (11) 2138-8949 

KEYWORDS: United States South America North America Brazil

INDUSTRY KEYWORDS: Natural Resources Manufacturing Other Manufacturing Packaging Forest Products

MEDIA:

STRAX: STRAX partners with HMD Global to develop and distribute a selection of Nokia-branded accessories across the world

PR Newswire

STOCKHOLM, Dec. 2, 2020 /PRNewswire/ — STRAX and HMD Global, the home of Nokia phones, have formed a global partnership to jointly develop and distribute an exciting range of new Nokia-branded accessories, including the recently-announced Nokia Portable Wireless Speaker and protective cases for some of the newest Nokia smartphones. STRAX, the mobile accessories specialist, in partnership with HMD Global, will design, develop and manufacture Nokia-branded accessories, and distribute the range internationally.

HMD Global is the only major European mobile phone brand, delivering Nokia smartphones, feature phones and accessories across the globe.

“At HMD Global, we have founded our business on strategic partnerships – working with the best in the industry allows us to provide modern mobile technology accessible to everyone and deliver excellent experiences across the portfolio that you would expect from Nokia phones and accessories. As we further develop our accessories portfolio, we needed a partner that combines deep consumer market insights, design capabilities and a truly innovative spirit. All this, combined with STRAX’s ability to work with multiple distribution channels across the globe, makes this the perfect partnership. Stay tuned for new accessory announcements in the coming months,” says Alex Lambeek, Head of Accessories at HMD Global.

“It’s truly exciting to be working with HMD Global across such a trusted brand in phones and accessories.
Having formerly worked directly with Nokia as their largest accessories distributor in Europe, it is energizing and thrilling to be working in partnership with HMD Global with this iconic brand,” says Gudmundur Palmason, CEO of STRAX AB.

For further information please contact Gudmundur Palmason, CEO, STRAX AB, +46 8 545 017 50.

HMD Global press office:[email protected]

About HMD Global

Headquartered in Espoo, Finland, HMD Global Oy is the home of Nokia phones. HMD designs and markets a range of smartphones and feature phones targeted at a range of consumers and price points. With a commitment to innovation and quality, HMD is the proud exclusive licensee of the Nokia brand for phones and tablets. For further information, see www.hmdglobal.com.  HMD Global Oy is the exclusive licensee of the Nokia brand for phones & tablets. 
Nokia is a registered trademark of Nokia Corporation.

About STRAX

STRAX is a global leader in tech accessories that empower mobile lifestyles. Our portfolio of accessories brands covers all major product categories: Protection, Power, Personal Audio and Connectivity. In response to the ongoing pandemic, STRAX has recently pivoted into Health & Wellness, with an initial focus on personal protection equipment, such as face masks, gloves and sanitizers. Our success lies in a strong offline and online distribution network and best-in-class customer service, delivered by a stellar team. We develop and grow brands through an omnichannel approach, we operate two complementary businesses: Own brands – including Urbanista, Clckr, Richmond & Finch, Planet Buddies, xqisit, AVO+, and licensed brands such as adidas, Bugatti, Diesel, SuperDry and WeSC – and Distribution (traditional retail, enterprises and online marketplaces). In addition to own and licensed brands, STRAX distributes over 40 major mobile accessory bands and several health and wellness brands.We sell into all key sales channels ranging from telecom operators, mass merchants and consumer electronics to lifestyle retailers, large enterprises and direct to consumers online. Founded in Miami and Hong Kong in 1995, STRAX has since expanded worldwide. Today, we have over 200 employees in 13 countries, with our operational HQ and logistics center in Germany. STRAX is listed on the Nasdaq Stockholm stock exchange.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/strax/r/strax–strax-partners-with-hmd-global-to-develop-and-distribute-a-selection-of-nokia-branded-accesso,c3247795

The following files are available for download:


https://mb.cision.com/Main/661/3247795/1343126.pdf

Pr HMD Nokia

Cision View original content:http://www.prnewswire.com/news-releases/strax-strax-partners-with-hmd-global-to-develop-and-distribute-a-selection-of-nokia-branded-accessories-across-the-world-301183672.html

SOURCE Strax

Harris Williams Advises Midwest Dental on its Sale to Smile Brands Inc.

Harris Williams Advises Midwest Dental on its Sale to Smile Brands Inc.

RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Midwest Dental, a portfolio company of FFL Partners (FFL), on its sale to Smile Brands Inc. (Smile Brands), a portfolio company of Gryphon Investors (Gryphon). Midwest Dental is a leading dental service organization with over 230 clinics in 17 states. The transaction was led by James Clark, Andy Dixon, Tyler Bradshaw, Andrew Hoft and Cameron Thomas of the Harris Williams Healthcare & Life Sciences (HCLS) Group.

“Midwest Dental is a premier dental services organization with a legacy that spans more than 50 years. The company has a devoted base of patients of all ages and has become a trusted partner providing best-in-class support to its affiliated dental practices,” said James Clark, a managing director at Harris Williams. “It was a pleasure working with the teams at Midwest Dental and FFL on this transaction, and we are excited to see the strategic combination evolve over time.”

“The dental industry remains attractive to investors given its solid fundamentals and long-term growth dynamics. Midwest Dental’s rapid recovery following COVID-19 shutdowns demonstrates the strength of its operating model and management team, as well as the industry’s resilience and importance to overall patient health. We are excited to have had the opportunity to work with the company and to extend our successful track record in the sector,” added Andy Dixon, a managing director at Harris Williams.

Midwest Dental is a leading dental services organization, founded in 1968 as a single dental practice in rural Mondovi, Wisconsin. The company emphasizes patient satisfaction and improving dental health outcomes by providing an exceptional care environment for its over 350 affiliated dentists. Today, the company continues its philosophy supporting over 230 clinics across 17 states including Colorado, Connecticut, Illinois, Indiana, Iowa, Kansas, Massachusetts, Michigan, Minnesota, Missouri, New Hampshire, New Jersey, New Mexico, New York, Ohio, Pennsylvania and Wisconsin.

FFL is a San Francisco-based private equity firm with over $4.5 billion under management. For over twenty years, the firm has helped build industry-leading companies, supplying capital and advice to exceptional management teams to grow businesses and unlock value. FFL has deep experience in investing and operations and has brought large-company best practices and professional networks to smaller companies. Business growth has provided over 75% of the value created by FFL for its investors. FFL invests in business services, industrials and healthcare services.

Based in Irvine, California, Smile Brands is one of the largest providers of support services to dental groups in the United States. The organization’s award-winning culture has made it the only dental support organization on Glassdoor’s Best Places to Work for the past three years. Smile Brands’ affiliated dentists benefit from industry-leading business support services, so they can spend more time caring for patients and less time on the administrative, marketing and financial aspects of operating a dental practice. The organization supports approximately 420 affiliated practices and 60 brands across 18 states, including Arizona, Arkansas, California, Colorado, Florida, Illinois, Indiana, Maryland, Ohio, Oregon, Nevada, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington and Wisconsin. Smile Brands is a portfolio company of Gryphon, a leading middle market private equity firm based in San Francisco.

Based in San Francisco, Gryphon is a leading private equity firm focused on profitably growing and competitively enhancing middle market companies in partnership with experienced management. The firm has managed over $5.0 billion of equity investments and capital since 1997. Gryphon targets making equity investments of $50 million to $300 million in portfolio companies with enterprise values ranging from approximately $100 million to $600 million. Gryphon prioritizes investment opportunities where it can form strong partnerships with owners and executives to build leading companies, utilizing Gryphon’s capital, specialized professional resources and operational expertise.

Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across Industry Groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC).

The Harris Williams HCLS Group has experience across a broad range of sectors, including healthcare providers; payors and payor services; outsourced pharmaceutical services; medical device supply chain; healthcare IT; and pharmacy. For more information on the HCLS Group and other recent transactions, visit the HCLS Group’s section of the Harris Williams website.

Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 5th Floor, 6 St. Andrew Street, London EC4A 3AE, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: [email protected]). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.

For media inquiries, please contact Julia Moore at [email protected].

KEYWORDS: United States North America New York Virginia

INDUSTRY KEYWORDS: Professional Services Health Dental Finance Consulting Banking

MEDIA:

Logo
Logo

Albertsons Companies, Inc. Announces Proposed Senior Notes Offering

Albertsons Companies, Inc. Announces Proposed Senior Notes Offering

BOISE, Idaho–(BUSINESS WIRE)–
Albertsons Companies, Inc. (NYSE: ACI) (the “Company”) today announced its intention to offer $500 million in aggregate principal amount of additional 3.500% Senior Notes due 2029 (the “Additional Notes”). The Additional Notes will be issued under the same indenture as those issued by the Company on August 31, 2020. The Company and its subsidiaries, Safeway Inc., New Albertsons L.P. and Albertson’s LLC, will be co-issuers of the Additional Notes.

The Company intends to use the net proceeds from the offering, together with approximately $224 million of cash on hand, to (i) fund a partial redemption (the “Redemption”) of $700 million in aggregate principal amount of its outstanding 5.750% Senior Notes due 2025 (the “Existing 2025 Notes”) and (ii) pay fees and expenses related to the Redemption and the issuance of the Additional Notes.

Pursuant to the terms of the indenture governing the Existing 2025 Notes, the Company will issue a conditional notice of redemption to redeem the outstanding Existing 2025 Notes. The Redemption will be conditional upon successful completion of the offering of the Additional Notes.

The Additional Notes will be offered in the United States to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to persons outside the United States in compliance with Regulation S under the Securities Act. The Additional Notes have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the Additional Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About Albertsons Companies

Albertsons Companies is a leading food and drug retailer in the United States. As of September 12, 2020, the Company operated 2,252 retail food and drug stores with 1,725 pharmacies, 398 associated fuel centers, 22 dedicated distribution centers and 20 manufacturing facilities. The Company operates stores across 34 states and the District of Columbia under 20 well-known banners including Albertsons, Safeway, Vons, Jewel-Osco, Shaw’s, Acme, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market, Haggen and Carrs. The Company is committed to helping people across the country live better lives by making a meaningful difference, neighborhood by neighborhood. In 2019 alone, along with the Albertsons Companies Foundation, the Company gave $225 million in food and financial support. In 2020, the Company made a $53 million commitment to community hunger relief efforts and a $5 million commitment to organizations supporting social justice. These efforts have helped millions of people in the areas of hunger relief, education, cancer research and treatment, social justice and programs for people with disabilities and veterans’ outreach.

Important Notice Regarding Forward-Looking Statements

This press release contains certain forward-looking statements. Statements that are not historical facts, including statements regarding the Company’s expectations, perspectives and projected financial performance, are forward-looking statements. The words “expect,” “believe,” “estimate,” “intend,” “plan” and similar expressions, when related to the Company and its subsidiaries, indicate forward-looking statements. The forward-looking statements are based on the Company’s current expectations and involve risks and uncertainties, including, but not limited to, risks and uncertainties regarding our current expectations and beliefs as to our ability to consummate the offering of Additional Notes, the intended use of proceeds thereof, other pending transactions, and other future events. These risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements include those related to the COVID-19 pandemic, about which there are still many unknowns, including the duration of the pandemic and the extent of its impact. The Company cautions that actual results could differ materially from the expectations described in the forward-looking statements. The Company also cautions that undue reliance should not be placed on any of the forward-looking statements, which speak only as of the date of this release. The Company undertakes no responsibility to update any of these forward-looking statements to reflect events or circumstances after the date of this report or to reflect actual outcomes. Information about certain potential factors that could affect our business and financial results and cause actual results to differ materially from those expressed or implied in any forward-looking statements are included under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in our Annual Report on Form 10-K for the fiscal year ended February 29, 2020, as amended, and our Quarterly Reports on Form 10-Q for the quarterly periods ended June 20, 2020 and September 12, 2020, which are on file with the U.S. Securities and Exchange Commission (the “SEC”), and may be contained in reports subsequently filed with the SEC and available at the SEC’s website at www.sec.gov.

Media Contact:

Melissa Plaisance

[email protected]| 925-226-5115

KEYWORDS: Idaho United States North America

INDUSTRY KEYWORDS: Other Retail Discount/Variety Retail Supermarket Convenience Store

MEDIA:

LendingTree Ranks America’s Most Expensive Small Towns

Vineyard Haven, Mass., Summit Park, Utah, and Jackson, Wyo. have the most expensive home prices among small towns in US

PR Newswire

CHARLOTTE, N.C., Dec. 2, 2020 /PRNewswire/ — In its latest study, LendingTree® analyzed the 50 US towns with populations under 50,000 with the most expensive median-home values. LendingTree then ranked the towns based on where home values were the highest and also compared home values in these towns to home values in the nation’s 50 largest cities. The goal: To determine whether towns are actually less expensive than cities.

Key findings

  • Small towns Vineyard Haven, Mass., Summit Park, Utah and Jackson, Wyo., have the most expensive home prices in the nation. The median home prices in these towns are $667,400, $598,900 and $563,100 respectively, meaning that a home in any of these areas costs about as much as a home in Los Angeles does. In fact, homes in Vineyard Haven and Summit Park are even more expensive than they are in Los Angeles.
  • Relative to income, homes in Vineyard Haven, Mass., Breckenridge, Colo. and Jackson, Wyo., are the most expensive. In these areas, the median home price is an average of 7.5 times higher than the median area income. This suggests that homebuyers in these towns have to stretch their budgets in order to buy a home.
  • Homes are the least expensive relative to median household income in Los Alamos, N.M., Gillette, Wyo. and Rock Springs, Wyo. The median home price in these areas is an average 2.7 times higher than the median area income, suggesting that homes in each town are relatively affordable. However, this isn’t all that surprising given that the median income in each town is higher than the overall average for the towns featured in LendingTree’s study, while home prices are lower than average.
  • On average, buying a home in one of the nation’s 50 most expensive towns is more costly than buying a home in one of the nation’s largest metros. An average of the median home prices across the towns featured in LendingTree’s study is $271,224. In the nation’s 50 largest cities, the average of median home prices is $269,180.
  • Although America’s most expensive towns are often more expensive than its largest cities, people who live in towns tend to earn less income than they would in a city. The median household income across the nation’s most expensive towns averages to $60,150, nearly $7,000 less than the average median household income across the nation’s 50 largest cities.

 




Top 10 Most Expensive Small Towns in US


 


Rank


Micropolitan area


Total population 2018


Median household income


Median home value


Home value to income ratio

1

Vineyard Haven, MA

17,313

$71,224

$667,400

9.37

2

Summit Park, UT

40,511

$100,453

$598,900

5.96

3

Jackson, WY

34,139

$78,452

$563,100

7.18

4

Breckenridge, CO

30,429

$77,589

$563,000

7.26

5

Steamboat Springs, CO

24,874

$74,273

$510,600

6.87

6

Heber, UT

30,523

$77,449

$388,900

5.02

7

Hood River, OR

23,131

$62,935

$355,100

5.64

8

Gardnerville Ranchos, NV

47,828

$62,503

$346,500

5.54

9

Juneau, AK

32,330

$88,213

$344,000

3.9

10

Hailey, ID

28,201

$51,207

$340,800

6.66

 

To view the full report, visit: https://www.lendingtree.com/home/mortgage/most-expensive-towns-in-america/

Methodology
Data used in this study comes from the 2017 American Community Survey 5-Year Estimates (the most recent survey which has the data necessary to perform this study). For the purposes of this study, LendingTree used micropolitan level data to approximate town level data.

When determining whether or not a home is affordable, the assumption is that an income earner will be able to afford a 20% down payment on the median home value in their area, and that they will receive a mortgage loan with a rate of 4.6% (the average rate offered to Americans). By using that data, the likely monthly payment and down payment for a median-priced home in a given micropolitan area were calculated.

An “affordable” monthly mortgage payment is based on the “28% rule,” which says that a person should not spend more than 28% of their yearly gross salary on yearly costs related to housing. This rule, while not necessarily applicable to everyone, is useful for homebuyers to keep in mind, as it helps to ensure that they are not overspending on their home and leaving too little money for other expenses.

By subtracting the monthly housing payment that is affordable to an income earner in the geographies highlighted in the study from the calculated housing payment that would be required to purchase a home valued at the median level, we are able to determine whether or not an average townsperson can reasonably afford to purchase a home in the town that they live in.

About LendingTree
LendingTree (NASDAQ: TREE) is the nation’s leading online marketplace that connects consumers with the choices they need to be confident in their financial decisions. LendingTree empowers consumers to shop for financial services the same way they would shop for airline tickets or hotel stays, comparing multiple offers from a nationwide network of over 500 partners in one simple search, and can choose the option that best fits their financial needs. Services include mortgage loans, mortgage refinances, auto loans, personal loans, business loans, student loans, insurance, credit cards and more. Through the My LendingTree platform, consumers receive free credit scores, credit monitoring and recommendations to improve credit health. My LendingTree proactively compares consumers’ credit accounts against offers on our network and notifies consumers when there is an opportunity to save money. In short, LendingTree’s purpose is to help simplify financial decisions for life’s meaningful moments through choice, education and support. LendingTree, LLC is a subsidiary of LendingTree, Inc. For more information, go to www.lendingtree.com, dial 800-555-TREE, like our Facebook page and/or follow us on Twitter @LendingTree

MEDIA CONTACT:


Stacia Werksma

[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/lendingtree-ranks-americas-most-expensive-small-towns-301183560.html

SOURCE LendingTree.com

ADP National Employment Report: Private Sector Employment Increased by 307,000 Jobs in November

PR Newswire

ROSELAND, N.J., Dec. 2, 2020 /PRNewswire/ — Private sector employment increased by 307,000 jobs from October to November according to the November ADP National Employment Report®.  Broadly distributed to the public each month, free of charge, the ADP National Employment Report is produced by the ADP Research Institute® in collaboration with Moody’s Analytics.  The report, which is derived from ADP’s actual payroll data, measures the change in total nonfarm private employment each month on a seasonally-adjusted basis.  



November 2020 Report Highlights


*

View the ADP National Employment Report Infographic at www.adpemploymentreport.com.

Total U.S. Nonfarm Private Employment:     307,000

By Company Size

Small businesses:     110,000

  • 1-19 employees     60,000
  • 20-49 employees     50,000

Medium businesses:     139,000

  • 50-499 employees     139,000

Large businesses:     58,000

  • 500-999 employees     45,000
  • 1,000+ employees     13,000

By Sector

Goods-producing:     31,000

  • Natural resources/mining     1,000
  • Construction     22,000
  • Manufacturing     8,000

Service-providing:     276,000

  • Trade/transportation/utilities     31,000
  • Information     0
  • Financial activities     8,000
  • Professional/business services     55,000
         – Professional/technical services     18,000
         – Management of
           companies/enterprises     1,000
         – Administrative/support services    36,000
  • Education/health services     69,000
         – Health care/social assistance     60,000
         – Education     9,000
  • Leisure/hospitality     95,000
  • Other services     18,000

* Sum of components may not equal total, due to rounding.

– Franchise Employment**

  • Franchise jobs     33,700

**Complete details on franchise employment can be found here.

“While November saw employment gains, the pace continues to slow,” said Ahu Yildirmaz, vice president and co-head of the ADP Research Institute. “Job growth remained positive across all industries and sizes.”

The matched sample used to develop the ADP National Employment Report was derived from ADP payroll data, which represents 460,000 U.S. clients employing nearly 26 million workers in the U.S. The October total of jobs added was revised from 365,000 to 404,000.  

To obtain additional information about the ADP National Employment Report, including additional charts, supporting data and the schedule of future release dates, or to subscribe to the monthly email alerts and RSS feeds, please visit www.adpemploymentreport.com.

The December 2020ADP National Employment Report will be released at 8:15 a.m. ET on January 6, 2021.

About the ADP National Employment Report
®
The ADP National Employment Report® is a monthly measure of the change in total U.S. nonfarm private employment derived from actual, anonymous payroll data of client companies served by ADP®, a leading provider of human capital management solutions.  The report, which measures nearly 26 million U.S. workers, is produced by the ADP Research Institute®, a specialized group within the company that provides insights around employment trends and workforce strategy, in collaboration with Moody’s Analytics, Inc.

Each month, ADP Research Institute issues the ADP National Employment Report as part of the company’s commitment to adding deeper insights into the U.S. labor market and providing businesses, governments and others with a source of credible and valuable information.  The ADP National Employment Report is broadly distributed to the public each month, free of charge.

The data for this report is collected for pay periods that can be interpolated to include the week of the 12th of each month, and processed with statistical methodologies similar to those used by the U.S. Bureau of Labor Statistics to compute employment from its monthly survey of establishments.  Due to this processing, this subset is modified to make it indicative of national employment levels; therefore, the resulting employment changes computed for the ADP National Employment Report are not representative of changes in ADP’s total base of U.S. business clients.

For a description of the underlying data and the statistical model used to create this report, please see the ADP National Employment Report: Development Methodology.

About the ADP Research Institute
The mission of the ADP Research Institute is to generate data-driven discoveries about the world of work, and to derive reliable economic indicators from these insights. We offer these findings to the world at large as our unique contribution to making the world of work better and more productive, and to bring greater awareness to the economy at large.

About Moody’s Analytics
Moody’s Analytics provides financial intelligence and analytical tools to help business leaders make better, faster decisions. Our deep risk expertise, expansive information resources, and innovative application of technology help our clients confidently navigate an evolving marketplace. We are known for our industry-leading and award-winning solutions, made up of research, data, software, and professional services, assembled to deliver a seamless customer experience. We create confidence in thousands of organizations worldwide, with our commitment to excellence, open mindset approach, and focus on meeting customer needs.

About ADP (NASDAQ – ADP)
Designing better ways to work through cutting-edge products, premium services and exceptional experiences that enable people to reach their full potential.  HR, Talent, Time Management, Benefits and Payroll. Informed by data and designed for people.   Learn more at ADP.com

ADP, the ADP logo, and Always Designing for People,
ADP National Employment Report, ADP Small Business Report, ADP National Franchise Report, and ADP Research Institute are registered trademarks of ADP, Inc. All other marks are the property of their respective owners.

Copyright © 2020 ADP, Inc. All rights reserved.

ADP-Media

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/adp-national-employment-report-private-sector-employment-increased-by-307-000-jobs-in-november-301183608.html

SOURCE ADP, Inc.

Healix International/HX Global launches 2021 Risk Forecasts New Risk Oracle Report Released to the Public

Boston, Dec. 02, 2020 (GLOBE NEWSWIRE) — As part of its continuing efforts to help businesses plan for and manage risks  associated with employee safety,  Healix International/HX Global is pleased to announce the release of its annual Risk Oracle report and Security Risk Map for 2021. The report provides essential resources for employers with global operations looking to anticipate and react risks anywhere in the world.

Although COVID-19 has dominated the focus of every business in 2020, around the world there also has been a steady stream of underlying challenges that have received less risk management focus, despite their potential to cause enduring operational disruption. The Risk Oracle report and Security Risk Map help to shed light on the less noticed, yet potentially damaging risks businesses might face.

As 2020 has demonstrated, 2021 is likely to also be a very busy year for challenging global events. As the report and Risk Map will show, some events will be predictable, some unprecedented. These types of risks – combined with a global drive for economic growth and the expectation of a new and as yet undefined “normal” – are expected to drive a greater need for robust organizational resilience plans than ever before.

Risk Oracle 2021: What’s inside?

  • Top risks to watch in 2021
  • A look back on regional highlights for the preceding year
  • Outlook for the global risk landscape for the year ahead
  • An introduction to Healix Sentinel
  • Regional Security Risk Maps

PLUS: The Risk Oracle report features a deep-dive into COVID-19, including expert analysis of the “vaccine race to save the world” and an assessment of what the new normal might  look like as the year progresses.


Click here to download the report.

Security Risk Map 2021

While risks can never be fully eliminated, understanding the evolving threats to an organization is essential. The Healix International/HX Global team draws upon specialized expertise from across its organization. It has assessed the risk landscape of every country around the world and assigned a security risk rating to each one. The risk ratings are designed to indicate the likelihood of being impacted by a security incident in a given country.


About HX Global


HX Global, the U.S. division of Healix International, has been providing assistance and travel risk consultancy solutions to some of the world’s most well-known corporations, governments and NGOs for over two decades. HX Global’s fully integrated team has the skill and experience to address the myriad risks facing today’s travellers. Its combined medical, travel and risk management expertise places HX Global in the unique position to deliver comprehensive, cost-effective solutions without compromising high-quality support for the end-user. To learn more, please visit www.hx-global.com.



For more information, please contact the HX Global Press Office:
Stephanie Miller, Sr. Communications Director, Americas
[email protected] 
+1 617 750 7907